 MONTREAL, May 20, 2021 GLOBE NEWSWIRE -- Sunshine Biopharma Inc. OTC PINK: SBFM, a pharmaceutical company focused on the research, development and commercialization of oncology and antiviral drugs, today announced that it has paid off 250,000 in variable rate convertible debt and is planning to soon eliminate the two similar items remaining on the books of the Company. The Companys application for uplisting to the OTCQB had been declined due to outstanding variable rate loans which were on the Companys financial statements at the time of the application. The Company can re-apply in October 2021. 